Baertsch, Marc-A
25  Ergebnisse:
Personensuche X
?
3

P-188: Carfilzomib, lenalidomide, and dexamethasone followe..:

Baertsch, Marc-A. ; Fougereau, Mathilde ; Hielscher, Thomas...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S140-S141 , 2021
 
?
4

Impact of cytogenetics at relapse on prognosis and benefit ..:

Baertsch, Marc-A. ; Schlenzka, Jana ; Hielscher, Thomas...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e286-e287 , 2019
 
?
5

Comparison of bortezomib versus lenalidomide maintenance th..:

Mai, Elias K. ; Baertsch, Marc-A. ; Hielscher, Thomas...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e43 , 2019
 
?
6

Efficacy and Tolerability of the Histone-Deacetylase Inhibi..:

Baertsch, Marc-A. ; Hillengass, Jens ; Schoenland, Stefan...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e119-e120 , 2017
 
?
7

High Cut-off Hemodialysis Combined with Bortezomib-Based Th..:

Baertsch, Marc-A. ; Raab, Marc S. ; Beimler, Jörg...
Clinical Lymphoma Myeloma and Leukemia.  17 (2017)  1 - p. e120 , 2017
 
?
 
?
 
1-15